Frank E Thomas's Net Worth
$3.49 Million
Who is Frank E Thomas?
Frank E Thomas has an estimated net worth of $3.49 Million. This is based on reported shares across multiple companies, which include Spero Therapeutics, Inc., Larimar Therapeutics, Inc., AMAG PHARMACEUTICALS INC., Orchard Therapeutics plc, CRITICAL THERAPEUTICS INC, and ESPERION THERAPEUTICS INC/MI.
SEC CIK
Frank E Thomas's CIK is 0001242616
Past Insider Trading and Trends
2022 was Frank E Thomas's most active year for acquiring shares with 14 total transactions. Frank E Thomas's most active month to acquire stocks was the month of January. 2024 was Frank E Thomas's most active year for disposing of shares, totalling 11 transactions. Frank E Thomas's most active month to dispose stocks was the month of December. 2006 saw Frank E Thomas paying a total of $1,618,729.10 for 1,075,885 shares, this is the most they've acquired in one year. In 2004 Frank E Thomas cashed out on 207,778 shares for a total of $1,707,230.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.3101
InvestorFrank E Thomas owns 55,000 units of Common Stock which is worth $72,055.50. From 2017 to 2024 Frank E Thomas acquired a total of 55,000 shares in Spero Therapeutics, Inc..
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +57.14% | 20K |
—
|
—
| 55K |
May 29
| |||
Form 4
| +133.33% | 20K |
—
|
—
| 35K |
Oct 5
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Larimar Therapeutics, Inc. (LRMR) Snapshot price: $8.05
InvestorFrank E Thomas owns 2,000 units of Common Stock which is worth $16,100.00. From 2014 to 2024 Frank E Thomas acquired a total of 2,000 shares in Larimar Therapeutics, Inc. at a cost of $22,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 4
|
∞
| 2K |
$11.00 | $22,000.00 | 2K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMAG PHARMACEUTICALS INC. No price found
President & COOFrank E Thomas owns 138,195 units of Common Stock.acquired a total of 169,900 shares in AMAG PHARMACEUTICALS INC. at a cost of $257,315.00, Frank also disposed a total of 76,705 shares of AMAG PHARMACEUTICALS INC. equalling to $3,606,084.35.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.02% | 24K |
—
|
—
| 138.19K |
Feb 23
| |||
Form 4
| +6.78% | 7.25K |
$26.97 | -$262,998.56 | 114.19K |
Feb 26 - Mar 1
| |||
Form 4
| -2.16% | -2.36K |
$61.71 | -$145,820.73 | 106.95K |
Aug 20
| |||
Form 4
|
—
|
0
|
$40.88 | -$779,100.00 | 109.31K |
Scheduled
|
Aug 5
| ||
Form 4
| -15.47% | -20.00K |
$69.47 | -$1,389,318.04 | 109.31K |
Jun 4
| |||
Form 4
| -3.20% | -4.28K |
$49.70 | -$212,666.30 | 129.31K |
Mar 3
| |||
Form 4
| +10.32% | 12.5K |
—
|
—
| 133.59K |
Feb 26
| |||
Form 4
| -5.50% | -7.05K |
$40.49 | -$285,292.54 | 121.09K |
Dec 17
| |||
Form 4
| +45.39% | 40K |
—
|
—
| 128.13K |
Aug 19
| |||
Form 4
| +6.79% | 5.6K |
—
|
—
| 88.13K |
Feb 27
| |||
Form 4
| -3.81% | -3.27K |
$23.23 | -$75,869.18 | 82.53K |
Dec 16
| |||
Form 4
| +85.45% | 18.8K |
—
|
—
| 40.8K |
Feb 28
| |||
Form 4
| +83.33% | 10K |
$15.60 | -$155,969.00 | 22K |
Scheduled
|
Jan 3
| ||
Form 4
| +71.43% | 5K |
$15.08 | -$75,400.00 | 12K |
Scheduled
|
Nov 30
| ||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Aug 1
| |||
Form 4
| +33.33% | 500 |
$15.86 | $7,930.00 | 2K |
Scheduled
|
Apr 2
| ||
Form 4
| +50.00% | 500 |
$15.81 | $7,905.00 | 1.5K |
Scheduled
|
Mar 1
| ||
Form 4
| +100.00% | 500 |
$16.56 | $8,280.00 | 1K |
Scheduled
|
Feb 1
| ||
Form 4
|
∞
| 500 |
$19.10 | $9,550.00 | 500 |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Orchard Therapeutics plc (ORTX) No price found
See RemarksFrank E Thomas used to own units in Ordinary Shares but no longer holds any shares there. From 2020 to 2024 Frank E Thomas acquired a total of 80,667 shares in Orchard Therapeutics plc at a cost of $74,638.00, Frank also disposed a total of 95,787 shares of Orchard Therapeutics plc equalling to $24,904.32.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -92.08K |
—
|
—
|
0
|
Jan 24
| |||
Form 4
| +27.75% | 20K |
$0.46 | $9,182.00 | 92.08K |
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +38.40% | 20K |
$0.46 | $9,182.00 | 72.08K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +23.76% | 10K |
$0.75 | $7,474.00 | 52.08K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +31.17% | 10K |
$2.44 | $24,400.00 | 42.08K |
Jan 29
| |||
Form 4
| +27.71% | 6.96K |
$6.72 | -$24,904.32 | 32.08K |
Jan 8 - Jan 11
| |||
Form 4
| +66.14% | 10K |
$2.44 | $24,400.00 | 25.12K |
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CRITICAL THERAPEUTICS INC No price found
President & CEOFrank E Thomas owns 72,033 units of Common Stock. From 2004 to 2007 Frank E Thomas acquired a total of 74,033 shares in CRITICAL THERAPEUTICS INC at a cost of $1,735,739.42.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.46% | 5K |
$2.12 | $10,620.00 | 72.03K |
Aug 22
| |||
Form 4
| +2.29% | 1.5K |
$2.24 | $3,360.00 | 67.03K |
Jun 13
| |||
Form 4
| +2.34% | 1.5K |
$2.69 | $4,035.00 | 65.53K |
Jun 6
| |||
Form 4
| +3.22% | 2K |
$2.75 | $5,500.00 | 64.03K |
Jun 4
| |||
Form 4
| +3.59% | 2.15K |
$1.59 | $3,415.32 | 62.03K |
May 31
| |||
Form 4
| +201.16% | 40K |
$40.00 | $1,600,000.00 | 59.88K |
Dec 27
| |||
Form 4
| +10.47% | 1.89K |
$1.66 | $3,129.10 | 19.89K |
Nov 30
| |||
Form 4
| +28.57% | 4K |
$3.90 | $15,600.00 | 18K |
Aug 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +7.69% | 1K |
$5.63 | $5,630.00 | 14K |
Nov 2
| |||
Form 4
| +8.33% | 1K |
$5.63 | $5,630.00 | 13K |
Sep 14
| |||
Form 4/A
|
∞
| 10K |
$5.63 | $56,300.00 | 10K |
Apr 26 - Apr 28
| |||
Form 4/A
| +20.00% | 2K |
$5.63 | $11,260.00 | 12K |
Jan 25
| |||
Form 4
| +1.69% | 2K |
$5.63 | $11,260.00 | 120K |
Jan 25
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||